CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

RUBICON RESEARCH LTD.

NSE : RUBICONBSE : 544578ISIN CODE : INE506V01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE1828.7038.15 (+2.13 %)
PREV CLOSE () 1790.55
OPEN PRICE () 1795.40
BID PRICE (QTY) 1826.15 (4)
OFFER PRICE (QTY) 1828.70 (270)
VOLUME 18385
TODAY'S LOW / HIGH ()1758.80 1829.00
52 WK LOW / HIGH ()571 1896.15
NSE1827.6037.6 (+2.1 %)
PREV CLOSE() 1790.00
OPEN PRICE () 1792.00
BID PRICE (QTY) 1827.60 (140)
OFFER PRICE (QTY) 1828.50 (25)
VOLUME 289343
TODAY'S LOW / HIGH() 1758.10 1845.00
52 WK LOW / HIGH ()570.75 1899
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1999

Management Info :

Venkat Changavalli - Chairman Pratibha Pilgaonkar - Managing Director

Registered Office :

Address : Medone House, B-75,Road No. 33,Wagle Estate, Thane (West),
Thane,
Maharashtra-400604

Phone : 022- 61414000 / 50414000

Website : www.rubicon.co.in

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
29Aug Rubicon Research informs about disclos
Rubicon Research has informed thatit encloseddisclosure under Regulation..
27Aug Rubicon Research informs about disclo
Rubicon Research has informed that the exchange has received the disclos..
27Aug General Atlantic sells 8.4% stake in R
The US-based global investment firm General Atlantic, through its affili..
23Jul Rubicon Research soars on acquiring ma
Rubicon Research is currently trading at Rs. 1515.00, up by 50.10 points..
22Jul Rubicon Research acquires manufacturin
Rubicon Research has acquired manufacturing facility in East Brunswick,..
Financials
in Millions
QTR Jun 26 ANNUAL 26
Net Profit824.491881.65
Gross Profit 1106.57 2527.79
Operating Profit 1272.383214.87
Net Sales 4277.313060.82
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 25560.75 (1.14%)
M.Cap ( in Cr)
54249.47
Onesource Specialty (BSE)
 1601.30 (3.61%)
M.Cap ( in Cr)
18389.52
SMS Pharmaceuticals (BSE)
 462.10 (10.25%)
M.Cap ( in Cr)
4336.09
Torrent Pharma (BSE)
 4968.90 (0.82%)
M.Cap ( in Cr)
189012.40
Laurus Labs (BSE)
 1971.60 (1.84%)
M.Cap ( in Cr)
106441.51
Shareholding Pattern
PROMOTERS 59.76%
NON-INSTITUTION 23.3%
MUTUAL FUNDS/UTI 7.23%
FI/BANKS/INSURANCE 0.18%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
No Data Found

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX74858.22-44.37 (-0.06%)
NIFTY23396.55-81.25 (-0.35%)
Dow Jones 52064.10-316.56 (-0.60%)
Nasdaq 26081.72-171.62 (-0.65%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI